Successful Treatment With Ustekinumab for Chronic Refractory Pouchitis.

Suppr

超能文献

作者信息

Tran-Minh My-Linh, Allez Matthieu, Gornet Jean-Marc

机构信息

Department of Gastroenterology, Hôpital Saint-Louis, Université Denis Diderot, Paris,France.

出版信息

J Crohns Colitis. 2017 Sep 1;11(9):1156. doi: 10.1093/ecco-jcc/jjx018.

DOI:10.1093/ecco-jcc/jjx018

PMID:28199485

Abstract

摘要

相似文献

Successful Treatment With Ustekinumab for Chronic Refractory Pouchitis.

J Crohns Colitis. 2017 Sep 1;11(9):1156. doi: 10.1093/ecco-jcc/jjx018.

Effective use of ustekinumab for prepouch ileitis without improvement of concomitant pouchitis.

Tech Coloproctol. 2018 Mar;22(3):251-252. doi: 10.1007/s10151-018-1754-9. Epub 2018 Feb 9.

Efficacy of Vedolizumab in Patients with Antibiotic and Anti-tumor Necrosis Alpha Refractory Pouchitis.维多珠单抗治疗对抗生素和抗肿瘤坏死因子难治性袋状结肠炎患者的疗效

Inflamm Bowel Dis. 2017 Jan;23(1):E5-E6. doi: 10.1097/MIB.0000000000000992.

Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis.乌司奴单抗治疗慢性抗生素难治性 pouchitis 有效。

Dig Dis Sci. 2019 Dec;64(12):3596-3601. doi: 10.1007/s10620-019-05697-1. Epub 2019 Jun 11.

Clinical Features of Refractory Pouchitis with Penetrating Lesions and the Efficacy of Infliximab Treatment for Patients with Ulcerative Colitis after Restorative Proctocolectomy.保留直肠结肠切除术治疗溃疡性结肠炎后难治性袋炎合并穿透性病变的临床特征及英夫利昔单抗治疗的疗效

Digestion. 2015;92(3):147-55. doi: 10.1159/000438922.

One year of infliximab therapy successfully improved a case of refractory pouchitis without the use of antibiotics.英夫利昔单抗治疗一年成功改善了一例难治性袋炎，且未使用抗生素。

Intern Med. 2014;53(22):2581-3. doi: 10.2169/internalmedicine.53.2793. Epub 2014 Nov 15.

Successful Treatment With Vedolizumab in a Patient With Chronic Refractory Pouchitis and Primary Sclerosing Cholangitis.维多珠单抗成功治疗一例慢性难治性袋炎合并原发性硬化性胆管炎患者

J Crohns Colitis. 2017 Dec 4;11(12):1507-1508. doi: 10.1093/ecco-jcc/jjx090.

Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: a multicenter study.英夫利昔单抗解救治疗慢性难治性袋状结肠炎患者的疗效：一项多中心研究。

Inflamm Bowel Dis. 2012 May;18(5):812-7. doi: 10.1002/ibd.21821. Epub 2011 Aug 8.

Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch-Anal Anastomosis for Ulcerative Colitis.柳氮磺胺吡啶预防溃疡性结肠炎行结直肠切除回肠储袋肛管吻合术后储袋炎

Dig Dis Sci. 2017 Apr;62(4):1016-1024. doi: 10.1007/s10620-017-4454-9. Epub 2017 Jan 21.

Ustekinumab Rescue Therapy in a Patient With Chronic Refractory Pouchitis.优特克单抗用于慢性难治性袋炎患者的挽救治疗

J Crohns Colitis. 2018 Jul 30;12(8):1008-1009. doi: 10.1093/ecco-jcc/jjy037.

引用本文的文献

Navigating Chronic Pouchitis: Pathogenesis, Diagnosis, and Management.慢性袋炎的诊治：发病机制、诊断与管理

Gastroenterol Hepatol (N Y). 2025 Jan;21(1):46-58.

Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment.老年患者回肠储袋肛管吻合术：术后结果及储袋炎治疗综述

Curr Treat Options Gastroenterol. 2022 Dec;20(4):564-581. doi: 10.1007/s11938-022-00405-x. Epub 2022 Dec 6.

Medical treatment of pouchitis: a guide for the clinician.储袋炎的医学治疗：临床医生指南

Therap Adv Gastroenterol. 2021 Jun 27;14:17562848211023376. doi: 10.1177/17562848211023376. eCollection 2021.

Is Ustekinumab Effective in Refractory Crohn's Disease of the Pouch and Chronic Pouchitis? A Systematic Review.乌司奴单抗治疗难治性 pouchitis 和慢性 pouch 炎的效果如何？一项系统评价。

Dig Dis Sci. 2022 Jun;67(6):1948-1955. doi: 10.1007/s10620-021-07002-5. Epub 2021 Jun 7.

Outcomes and Management of the Ileal Pouch-Anal Anastomosis in the Elderly.老年患者回肠贮袋肛管吻合术的结局与管理

Curr Treat Options Gastroenterol. 2018 Sep;16(3):275-288. doi: 10.1007/s11938-018-0184-0.

Anti-Inflammatory Biologics and Anti-Tumoral Immune Therapies-Associated Colitis: A Focused Review of Literature.抗炎生物制剂和抗肿瘤免疫疗法相关的结肠炎：文献综述

Gastroenterology Res. 2018 Jun;11(3):174-188. doi: 10.14740/gr1041w. Epub 2018 May 31.

Effective use of ustekinumab for prepouch ileitis without improvement of concomitant pouchitis.

Tech Coloproctol. 2018 Mar;22(3):251-252. doi: 10.1007/s10151-018-1754-9. Epub 2018 Feb 9.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验